Cancer · Austria
Endometrial cancer
How is it diagnosed today? Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.7 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Hysterectomy, then radiotherapy or chemo if needed. MedlinePlus
4 medicines are approved for this disease in Austria:
- Dostarlimab (Jemperli) – approved in 2021
- Durvalumab (Imfinzi) – approved in 2018
- Olaparib (Lynparza) – approved in 2014
- Pembrolizumab (Keytruda, Keytruda Qlex) – approved in 2015
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (3)
- Cisplatin (Cisplatine Teva, Cisplatine Viatris) – approved for it in France
- Hydroxyprogesterone caproate (Hydroxyprogesterone Caproate) – approved for it in the US
- Lenvatinib (Lenvima, Lenvatinib Sandoz, Lenvatinib-Teva) – approved for it in the US and Switzerland
Being tested in people
7 open trials in Austria, 341 worldwide. See the trials
- Anlotinib hydrochloride capsule + TQB2450 injection (Phase 3)
- anti-PD1 agent therapy - 1 year (Phase 3)
- anti-PD1 agent therapy - 2 years (Phase 3)
- Bevacizumab (Phase 3)
Only in the lab or in animals
Not counted yet for this disease.
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
1 open trial in Austria with these filters
EIK1005 alone or with pembrolizumab for advanced solid tumors
NCT07262619 · ClinicalTrials.gov
- Linz – Ordensklinikum Linz Elisabethinen
Age 18 and over
Contact the trial team
Available abroad (115 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests GSK5460025 alone or combined with other drugs in solid tumors
NCT07213609 · ClinicalTrials.gov
Countries: Denmark, Spain, France and 6 more
- København Ø, Denmark – hospital not given
- Barcelona, Spain – hospital not given
- Madrid, Spain – hospital not given
Age 18 and over
Contact the trial teamTests PLN-101095 with pembrolizumab in adults with advanced solid tumors
NCT06270706 · ClinicalTrials.gov
Countries: Spain, United States
- Barcelona, Spain – Hospital Universitari Vall d'Hebron - VHIO
- Barcelona, Spain – START Barcelona Hospital HM Nou Delfos
- Barcelona, Spain – Hospital Universitari Quirónsalud (NEXT Barcelona)
Age 18 and over
Contact the trial teamTests CTIM-76 in adults with recurring ovarian cancer and other solid tumors
NCT06515613 · ClinicalTrials.gov
Countries: Spain, France, United Kingdom and 1 more
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Hospital Universitario Fundación Jiménez Díaz
- Madrid, Spain – Hospital Universitario 12 de Octubre
Age 18 and over
Contact the trial teamTests VS-7375 in adults with advanced solid tumors carrying a KRAS G12D mutation
NCT07020221 · ClinicalTrials.gov
Countries: Spain, France, Australia and 1 more
- Barcelona, Spain – Vall d'Hebron Instituto de Oncologia
- Logroño, Spain – START - Rioja Hospital Universitario San Pedro
- Madrid, Spain – START Madrid CIOCC - Hospital HM Sanchinarro
Age 18 and over
Contact the trial teamIDE034 for Advanced Solid Tumors Including Lung, Colorectal, Ovarian and Prostate Cancers
NCT07503808 · ClinicalTrials.gov
Countries: Spain, Georgia, United States
- Madrid, Spain – Hospital Universitario HM Sanchinarro
- Batumi, Georgia – LTD High Technology Hospital Medcenter
- Tbilisi, Georgia – Multiprofile Clinic Consilium Medulla
Age 18 and over
Contact the trial teamTests Sofe-M in adults with selected advanced solid tumors
NCT06400472 · ClinicalTrials.gov
Countries: Spain, France, Italy and 3 more
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Hospital Universitario 12 de Octubre
- Valencia, Spain – Hospital Clinico Universitario de Valencia
Age 18 and over
Contact the trial teamTests ADU-1805 alone and with pembrolizumab in advanced solid tumors
NCT05856981 · ClinicalTrials.gov
Countries: Belgium, Spain, United States
- Charleroi, Belgium – Grand Hopital de Charleroi (GHdC) - Hopital Notre Dame
- Madrid, Spain – Hospital General Universitario Gergorio Maranon
- Madrid, Spain – Hosp 12 de Octubre
Age 18 and over
Contact the trial teamTests MGC026 in people with advanced solid tumors
NCT06242470 · ClinicalTrials.gov
Countries: United Kingdom, Australia, United States
- Oxford, United Kingdom – Oxford University Hospitals NHS Foundation Trust
- Sutton, United Kingdom – The Royal Marsden NHS Foundation Trust
- Auchenflower, Australia – ICON Cancer Centre Wesley
Age 18 and over
Contact the trial teamTests TER-2013 in advanced solid tumors with PI3K pathway changes
NCT07109726 · ClinicalTrials.gov
Countries: Spain, Ireland, Portugal and 2 more
- Barcelona, Spain – START Research Center at Hospital HM Nou Delfos
- Barcelona, Spain – Hospital Universitario General de Catalunya
- Madrid, Spain – Md Anderson Cancer Center Madrid-Hospiten
Age 18 and over
Contact the trial teamTests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors
NCT06330064 · ClinicalTrials.gov
Countries: Belgium, Germany, Spain and 15 more
- Charleroi, Belgium – Grand Hopital de Charleroi
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – Centre Hospitalier Universitaire de Liège
Age 18 and over
Contact the trial teamTests ART0380 Pill Alone or With Chemotherapy for Advanced Solid Tumors
NCT04657068 · ClinicalTrials.gov
Countries: Spain, France, United Kingdom and 1 more
- A Coruña, Spain – Hospital Teresa Herrera (CHUAC)
- A Coruña, Spain – Hospital Clínico Universitario de Santiago (CHUS)
- Badalona, Spain – Institut Catala d'Oncologia Badalona, Hospital Germans Trias I Pujol
Age 18 and over
Contact the trial teamTests BNT329 safety in adults with advanced solid tumors expressing CA19-9
NCT07186842 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 2 more
- Bochum, Germany – St. Josef-Hospital im Katholischen Klinikum Bochum
- München, Germany – Klinikum der Universität München
- Ulm, Germany – Universitaetsklinikum Ulm
Age 18 and over
Contact the trial teamTests AZD8205 alone or combined in advanced solid tumors
NCT05123482 · ClinicalTrials.gov
Countries: Belgium, Spain, United Kingdom and 12 more
- Anderlecht, Belgium – hospital not given
- Leuven, Belgium – hospital not given
- Barcelona, Spain – hospital not given
Age 18 and over
Contact the trial teamTests XmAb541 for safety in people with advanced solid tumors
NCT06276491 · ClinicalTrials.gov
Countries: Belgium, Denmark, Spain and 3 more
- Kortrijk, Belgium – AZ Groeninge
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – CHU de Liège
Age 15 and over
Contact the trial teamTests BMS-986500 alone or with other drugs in advanced cancers
NCT06997029 · ClinicalTrials.gov
Countries: Denmark, Japan, United States
- Odense C, Denmark – Odense University Hospital
- Hirakata, Japan – Kansai Medical University Hospital
- Kashiwa, Japan – National Cancer Center Hospital East
Age 18 and over
Contact the trial teamTests AZD9574 alone and with other cancer drugs in advanced solid tumours
NCT05417594 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 4 more
- Bayern, Germany – hospital not given
- Berlin, Germany – hospital not given
- Heidelberg, Germany – hospital not given
Ages 18 to 130
Contact the trial teamTests AZD5335 alone or with other drugs in advanced solid tumors
NCT05797168 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 9 more
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Freiburg im Breisgau, Germany – Medical Center- University of Freiburg
- Hanover, Germany – Medizinische Hochschule Hannover
Ages 18 to 130
Contact the trial teamTests rezatapopt in advanced solid tumors with a TP53 Y220C mutation
NCT04585750 · ClinicalTrials.gov
Countries: Germany, Spain, France and 6 more
- Augsburg, Germany – Universitätsklinikum Augsburg
- Essen, Germany – Universitätsklinikum Essen
- Frankfurt am Main, Germany – Universitätsklinikum Frankfurt
Age 12 and over
Contact the trial teamTests ubamatamab alone or with cemiplimab in recurrent ovarian and uterine cancers
NCT03564340 · ClinicalTrials.gov
Countries: Belgium, Spain, France and 7 more
- Edegem, Belgium – Antwerp University Hospital
- Leuven, Belgium – UZ Leuven
- Badalona, Spain – Institut Catala d'Oncologia
Age 18 and over
Contact the trial teamTests REGN5668 with other drugs in women with ovarian or uterine cancer
NCT04590326 · ClinicalTrials.gov
Countries: Belgium, Spain, France and 2 more
- Leuven, Belgium – UZ Leuven
- Girona, Spain – Institut Català d'Oncologia
- Madrid, Spain – Hospital Universitario Fundación Jiménez Díaz
Age 18 and over
Contact the trial teamTests elironrasib and daraxonrasib in advanced solid tumors with KRAS G12C mutation
NCT06128551 · ClinicalTrials.gov
Countries: Germany, Spain, France and 4 more
- Cologne, Germany – Universitäts Klinikum Köln
- Esslingen am Neckar, Germany – Klinikum Esslingen GmbH
- Moers, Germany – Krankenhaus Bethanien Moers
Age 18 and over
Contact the trial teamTests BL-B01D1 in adults with advanced solid cancers including lung cancer
NCT05983432 · ClinicalTrials.gov
Countries: Spain, France, Italy and 2 more
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Hospital Beata María Ana
Age 18 and over
Contact the trial teamTests BI 3820768 dose tolerability in advanced germ cell, endometrial, or ovarian cancer
NCT07306559 · ClinicalTrials.gov
Countries: Germany, Spain, France and 1 more
- Munich, Germany – LMU Klinikum Muenchen AöR
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Clinica Universidad de Navarra
Age 18 and over
Contact the trial teamTests tulmimetostat alone and with enzalutamide in advanced cancers
NCT04104776 · ClinicalTrials.gov
Countries: Spain, France, United Kingdom and 4 more
- Barcelona, Spain – Hospital Clinic de Barcelona
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Girona, Spain – Institut Català d'Oncologia
Age 18 and over
Contact the trial teamTesting STAR0602 alone and with chemotherapy in advanced solid tumors
NCT05592626 · ClinicalTrials.gov
Countries: Spain, France, Canada and 1 more
- Barcelona, Spain – Vall d'Hebron Institute of Oncology
- Madrid, Spain – START Madrid-FJD
- Madrid, Spain – Hospital Universitario Quirónsalud Madrid
Age 18 and over
Contact the trial teamTests a new drug, alone and with pembrolizumab, in advanced solid tumors
NCT05208762 · ClinicalTrials.gov
Countries: Belgium, Germany, Spain and 8 more
- Anderlecht, Belgium – Institut Jules Bordet
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
Age 18 and over
Contact the trial teamTests tersolisib alone and combined with other cancer drugs in advanced solid tumors
NCT05768139 · ClinicalTrials.gov
Countries: Belgium, Germany, Spain and 5 more
- Anderlecht, Belgium – Institut Jules Bordet
- Leuven, Belgium – UZ Leuven
- Erlangen, Germany – Universitaetsklinikum Erlangen AöR
Age 18 and over
Contact the trial teamTests farletuzumab ecteribulin in adults with certain solid tumors
NCT04300556 · ClinicalTrials.gov
Countries: Spain, France, United Kingdom and 1 more
- Badalona, Spain – Institut Catala d'Oncologia
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Valencia, Spain – Hospital Clinico Universitario de Valencia
Age 18 and over
Contact the trial teamTests MK-8294 alone in adults with advanced solid tumors
2024-516870-31-00 · EU Clinical Trials Register
Countries: Netherlands
- Amsterdam, Netherlands – Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
- Nijmegen, Netherlands – Radboud universitair medisch centrum Stichting
Age 18 and over
Contact the trial teamTesting a CAR-T cell therapy in advanced breast, stomach and endometrial cancers
NCT07593820 · ClinicalTrials.gov
Countries: Spain
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Barcelona, Spain – Hospital del Mar
Age 18 and over
Contact the trial teamTests MOv18 IgE in patients with folate receptor alpha tumours
NCT06547840 · ClinicalTrials.gov
Countries: United Kingdom
- Bristol, United Kingdom – Bristol Haematology and Oncology Centre
- Edinburgh, United Kingdom – Edinburgh Cancer Research Centre
- Leeds, United Kingdom – Leeds Teaching Hospitals NHS Trust
Age 18 and over
Contact the trial teamPersonalized Peptide Vaccine for High-Risk or Recurrent Endometrial Cancer
NCT07316361 · ClinicalTrials.gov
Countries: Greece
- Thessaloniki, Greece – Biogenea Pharmaceuticals Ltd & Interbalkan Medical Center - International Oncology Center
No age limit given in the registry
Contact the trial teamPembrolizumab With Ataluren for Advanced Colorectal and Endometrial Cancer
NCT04014530 · ClinicalTrials.gov
Countries: Netherlands
- Amsterdam, Netherlands – Stichting Amsterdam UMC
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests DT2216 with paclitaxel in ovarian cancer that returned after platinum treatment
NCT06964009 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Beth Israel Deaconess Medical Center (BIDMC)
- Boston, United States – Brigham and Women's Hospital
- Boston, United States – Dana-Farber Cancer Institute
Age 18 and over
Contact the trial teamStudy of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
NCT04683653 · ClinicalTrials.gov
Countries: United States
- Atlanta, United States – Winship Cancer Institute, Emory University
- Chicago, United States – University of Chicago
- Chicago, United States – University of Illinois at Chicago (UIC)
Age 18 and over
Contact the trial teamTesting different amounts of M1774 and ZEN-3694 for recurring ovarian and endometrial cancer
NCT05950464 · ClinicalTrials.gov
Countries: United States
- Albuquerque, United States – University of New Mexico Cancer Center
- Augusta, United States – Augusta University Medical Center
- Chicago, United States – University of Chicago Comprehensive Cancer Center
Age 18 and over
Contact the trial teamTests ST-01156 in people with advanced solid tumors
NCT07197554 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Mass General Brigham Cancer Institute
- Boston, United States – Dana-Farber Cancer Institute
- Duarte, United States – The City of Hope National Medical Center
Age 16 and over
Contact the trial teamTesting KST-6051 in advanced cancers with a KRAS mutation
NCT07458347 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Mass General Brigham Cancer Institute at Massachusetts General Hospital
- Fairfax, United States – NEXT Virginia
- Houston, United States – The University of Texas MD Anderson Cancer Center
Age 18 and over
Contact the trial teamTesting OPB-201 cell therapy for recurrent endometrial cancer and platinum-resistant ovarian cancer
NCT07664735 · ClinicalTrials.gov
Countries: United States
- Atlanta, United States – Emory Winship Cancer Institute
- Detroit, United States – Karmanos Cancer Institute
- Houston, United States – MD Anderson Cancer Center
Age 18 and over
Contact the trial teamTests a HER2 vaccine with immune drugs in advanced endometrial cancer
NCT06253494 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 18 to 120
Contact the trial team
Showing 40 of 115. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Targeted next-generation sequencing-based mutational signature analysis in endometrial cancer: utility and limitations across molecular subtypes.J Pathol Transl Med · 2026-11-10
- ReviewGATA2: A Custodian of Endometrial Identity: Guarding the Uterine Lining in Health and Disease.Bioessays · 2026-11-01
- N6-methyladenosine reader IGF2BP3 promotes endometrial cancer progression via modification of circ-EPB41L2 expression.Oncol Lett · 2026-11-03
- In peopleEndometrial cancer outcomes among women with disabilities: treatment access and survival disparities using nationwide Korean data.BMC Health Serv Res · 2026-08-21
- ReviewMenstrual Disorders: Postmenopausal Uterine Bleeding.FP Essent · 2026-11-01
Is it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (5)
- ENGAGe - European Network of Gynaecological Cancer Advocacy Groups (ESGO)
ESGO network of 80+ gynaecological cancer patient groups; member list with country filter.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- International Gynecologic Cancer Advocacy Network
Advocacy network of the International Gynecologic Cancer Society: annual advocacy summit, education, advocacy directory; free patient education for survivors and carers
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.